Continuous versus intermittent administration of ceftazidime in experimental Klebsiella pneumoniae pneumonia in normal and leukopenic rats. - Wikidata - awgldk - TriplyDB

Continuous versus intermittent administration of ceftazidime in experimental Klebsiella pneumoniae pneumonia in normal and leukopenic rats.

Continuous versus intermittent administration of ceftazidime in experimental Klebsiella pneumoniae pneumonia in normal and leukopenic rats.

http://www.wikidata.org/entity/Q35652730

about

Pharmacodynamics of fluconazole in a murine model of systemic candidiasis.Altered pharmacokinetics of piperacillin in febrile neutropenic patients with hematological malignancy Pharmacodynamics of daptomycin in a murine thigh model of Staphylococcus aureus infection.Cefepime, piperacillin-tazobactam, and the inoculum effect in tests with extended-spectrum beta-lactamase-producing Enterobacteriaceae.Clinical pharmacokinetics of cefamandole and ceftazidime administered by continuous intravenous infusion.Continuous infusion versus intermittent administration of ceftazidime in critically ill patients with suspected gram-negative infections Antimicrobial effects of continuous versus intermittent administration of carbapenem antibiotics in an in vitro dynamic model.In vitro pharmacodynamics of ceftazidime against Pseudomonas aeruginosa isolates from cystic fibrosis patients Once daily ceftriaxone and gentamicin for the treatment of febrile neutropenia.Steady-state pharmacokinetics of imipenem in febrile neutropenic cancer patients.Comparative activities of ciprofloxacin and ceftazidime against Klebsiella pneumoniae in vitro and in experimental pneumonia in leukopenic rats Continuous infusion of beta-lactam antibiotics Pharmacokinetic/pharmacodynamic relationships of antimicrobial drugs used in veterinary medicine.Continuous beta-lactam infusion in critically ill patients: the clinical evidence Antibacterial dosing in intensive care: pharmacokinetics, degree of disease and pharmacodynamics of sepsis.Antibiotic tissue penetration and its relevance: impact of tissue penetration on infection response.Bench-to-bedside review: Appropriate antibiotic therapy in severe sepsis and septic shock--does the dose matter?Impact of dosage schedule of antibiotics on the treatment of serious infections.Antimicrobial treatment of febrile neutropenia: pharmacokinetic-pharmacodynamic considerations.Continuous and Prolonged Intravenous β-Lactam Dosing: Implications for the Clinical Laboratory.Role of pharmacokinetics in the outcome of infections.Postantibiotic sub-MIC effects of vancomycin, roxithromycin, sparfloxacin, and amikacin Pharmacodynamic effects of subinhibitory concentrations of beta-lactam antibiotics in vitro.Beta-lactam antibiotics: is continuous infusion the preferred method of administration?Continuous infusion of ceftazidime in febrile neutropenic patients with acute myeloid leukemia.Impact of the dosage schedule on the efficacy of ceftazidime, gentamicin and ciprofloxacin in Klebsiella pneumoniae pneumonia and septicemia in leukopenic rats.Continuous infusion of antibiotics in the critically ill: The new holy grail for beta-lactams and vancomycin?Pharmacodynamics and alternative antimicrobial dosing regimens Effect of treatment duration on pharmacokinetic/pharmacodynamic indices correlating with therapeutic efficacy of ceftazidime in experimental Klebsiella pneumoniae lung infection.In vivo and in vitro study of several pharmacodynamic effects of meropenem.Effects of subminimal inhibitory concentrations of amoxicillin against Actinobacillus pleuropneumoniae.Impact of the duration of infection on the activity of ceftazidime, gentamicin and ciprofloxacin in Klebsiella pneumoniae pneumonia and septicemia in leukopenic rats.Exposure time-dependent bactericidal activities of amoxicillin against Actinobacillus pleuropneumoniae; an in vitro and In vivo pharmacodynamic model.Efficacy evaluation of iclaprim in a neutropenic rat lung infection model with methicillin-resistant Staphylococcus aureus entrapped in alginate microspheres.

P2860

Q33695281-D4674725-62A9-4E8A-B1F1-159A0E1C2D39 Q33797868-B6B86711-0172-4E59-AA05-186C0BF8C9AB Q33981666-9CE2D47B-48A7-403C-B321-9860F48B2148 Q33983667-A64C994F-1AD2-407E-8751-C8AAB2E2EB7F Q35013772-BA20360D-70AD-40B5-AD85-070BF4891CA1 Q35123123-A7B2261F-1A7D-4BFD-AB6E-9C5D24BFE32E Q35136449-4EA0B951-9AD2-49F4-949E-B6D20C0F0B2E Q35138316-F3363464-BCF2-451D-B767-3CBE4DD65E1D Q35262273-4B62988E-0A6C-4387-865D-75FF60B23FA8 Q35541720-AD3423AF-9D50-4DD3-B576-8AEC07F8B082 Q35543546-2D0D8150-2977-4611-9C0C-F5BFA9B38056 Q35656806-A1AB1C0F-2168-4735-851D-E8DA9405F4A7 Q35985436-589BC543-E27C-4A4F-BB57-A8AB7E020FB1 Q36329228-F71F2719-5ED4-4A35-8B61-63B645492E74 Q36554698-04697728-4B75-470A-A5C3-A9B756CE0570 Q36863646-AA5A00C1-5C47-4AFD-A528-B65860134F86 Q37516599-CCCF4DB7-6B85-4D3C-801C-C4950C53DF1C Q38035302-61D95796-73F6-477E-B8AF-7671E808DBC2 Q38117578-65C4F96C-5116-4E9B-B7D1-134BAD77DE09 Q38896040-BA95ABA5-6AA3-427D-8869-D3FD896E13BE Q39639407-CD079FF6-9211-43F5-82E3-5A972EA4E291 Q39881775-43CD2009-3493-4EED-8917-0E2ABB62324B Q40087367-FE63F604-93E4-497F-909B-1E57585B4A71 Q40459002-FA954BAD-DA8C-4CE7-B4E4-5A0BEBD50C7B Q40688395-BFD03B09-93D4-410C-84F2-3E40B34E5761 Q41810184-8F54270B-F94C-4B9A-9C41-D2BF3A470571 Q42432137-A0F0A22B-B3AD-492E-9FD1-AFBCC65DDCEB Q42543348-25E994D0-6F31-40E0-9412-1FDDE98A1CAC Q43152276-B053C687-BF55-4662-BF62-C97E26364460 Q43771580-4031EFDF-E90A-4621-A659-C08432F2AD48 Q44251235-600DE515-6064-43A1-9464-4C16B80429D3 Q44613093-10344AAD-5815-4AF1-A485-264AF64BE3D6 Q44665771-C3400356-A2B1-4ECF-ADA0-742047BBDD6F Q49986454-7E4FDED2-0847-4C10-884B-06F56248075D

P2860

Continuous versus intermittent administration of ceftazidime in experimental Klebsiella pneumoniae pneumonia in normal and leukopenic rats.

http://www.wikidata.org/entity/Q35652730

description

1986 nî lūn-bûn

@nan

1986年の論文

@ja

1986年論文

@yue

1986年論文

@zh-hant

1986年論文

@zh-hk

1986年論文

@zh-mo

1986年論文

@zh-tw

1986年论文

@wuu

1986年论文

@zh

1986年论文

@zh-cn

name

Continuous versus intermittent ...... in normal and leukopenic rats.

@ast

Continuous versus intermittent ...... in normal and leukopenic rats.

@en

type

label

Continuous versus intermittent ...... in normal and leukopenic rats.

@ast

Continuous versus intermittent ...... in normal and leukopenic rats.

@en

prefLabel

Continuous versus intermittent ...... in normal and leukopenic rats.

@ast

Continuous versus intermittent ...... in normal and leukopenic rats.

@en

P1433

Q35652730-DD3428AE-D0B7-4F14-8F21-D371E794F2CC

P1476

Q35652730-ACD274AD-79CA-405D-B680-B97156606754

P2093

Q35652730-30F74F87-2116-45AC-A243-1F2D6843D078

Q35652730-3AC2E440-0CF2-49EE-861B-3BE72417C955

Q35652730-4026D7F1-9051-4BAE-BECB-5A8F688DB87B

Q35652730-6E4FFD96-4593-4A4E-85EA-538CC4611495

P2860

Q35652730-1582F01E-E5C8-45DE-B1DD-7B309BA0169C

Q35652730-30F34B6B-DE23-4CF9-84E3-E81777AF585F

Q35652730-39316FEB-4CB5-4668-8A19-5B6EC1C7FBCE

Q35652730-3AB4CB62-75B9-4959-A9AC-37442F2F0720

Q35652730-57B8A80B-551D-4ECF-8FD4-2F4564296104

Q35652730-5D054C7D-6809-42A3-A15D-CA6836AEAB55

Q35652730-5E856EAF-9C7D-40B5-87C9-A25FA61B567A

Q35652730-74474A84-2D31-4BFF-9B20-C148A538FDEE

Q35652730-903B8CAB-7142-491D-8954-42B823CA916F

Q35652730-9665EB67-D17D-4924-B743-9E0DD71ED96E

P304

Q35652730-90D9F978-12A9-4E0E-8F21-8013C66D5B8B

P31

Q35652730-0BE3E26E-C810-4A63-9A95-E096CBB87BCE

P356

Q35652730-CC74C685-9C32-4282-AB25-1F2EC2081CFB

P407

Q35652730-866CC22C-3632-4843-9CB4-03693EB8AC58

P433

Q35652730-F05717FB-0236-4EB5-9597-9568E7BB655D

P478

Q35652730-879ECCF6-12E7-4BB6-8669-E29590CDB862

P577

Q35652730-D7CB9321-A2C6-4175-B223-809EC5DD30E7

P698

Q35652730-993C40BE-16A5-4D8D-B3E7-5CDEBAA59C73

P921

Q35652730-B094EA4D-8BA8-424D-B22F-8CA60208CDD7

P932

Q35652730-6A5E442D-21E7-48A2-9ACE-3A5967974180

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Continuous versus intermittent ...... in normal and leukopenic rats.

@en

P2093

Bakker-Woudenberg IA

http://www.w3.org/2001/XMLSchema#string

Michel MF

http://www.w3.org/2001/XMLSchema#string

Roosendaal R

http://www.w3.org/2001/XMLSchema#string

van den Berghe-van Raffe M

http://www.w3.org/2001/XMLSchema#string

P2860

Causes of death in febrile granulocytopenic cancer patients receiving empiric antibiotic therapy.

Simplified, accurate method for antibiotic assay of clinical specimens

Comparative effects of amoxycillin and ampicillin on the morphology of Escherichia coli in vivo and correlation with activity.

Influence of four modes of administration on penetration of aztreonam, cefuroxime, and ampicillin into interstitial fluid and fibrin clots and on in vivo efficacy against Haemophilus influenzae.

Effect of method of administration on extravascular penetration of four antibiotics.

Therapeutic activities of cefazolin, cefotaxime, and ceftazidime against experimentally induced Klebsiella pneumoniae pneumonia in rats.

Early bacterial clearance from murine lungs. Species-dependent phagocyte response

Current practices in antimicrobial dosing.

Dosage schedules of antimicrobial agents: a historical review.

Role of serial microbiologic surveillance and clinical evaluation in the management of cancer patients with fever and granulocytopenia.

P304

403-408

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.30.3.403

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

30

http://www.w3.org/2001/XMLSchema#string

P577

1986-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

3535664

http://www.w3.org/2001/XMLSchema#string

P921

Klebsiella pneumoniae

P932

180569

http://www.w3.org/2001/XMLSchema#string